Your browser doesn't support javascript.
loading
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib.
Brase, Jan C; Walter, Robert F H; Savchenko, Alexander; Gusenleitner, Daniel; Garrett, James; Schimming, Tobias; Varaljai, Renata; Castelletti, Deborah; Kim, Ju; Dakappagari, Naveen; Schultz, Ken; Robert, Caroline; Long, Georgina V; Nathan, Paul D; Ribas, Antoni; Flaherty, Keith T; Karaszewska, Boguslawa; Schachter, Jacob; Sucker, Antje; Schmid, Kurt W; Zimmer, Lisa; Livingstone, Elisabeth; Gasal, Eduard; Schadendorf, Dirk; Roesch, Alexander.
Afiliación
  • Brase JC; Novartis Pharma AG, Basel, Switzerland.
  • Walter RFH; Department of Pathology, University Hospital Essen, Essen, Germany.
  • Savchenko A; Ruhrlandklinik, West German Lung Center, University Hospital Essen, University of Duisburg-Essen, Germany.
  • Gusenleitner D; Oncology Precision Medicine, Novartis, Cambridge, Massachusetts.
  • Garrett J; Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts.
  • Schimming T; Novartis Pharmaceuticals Corporation, Cambridge, Massachusetts.
  • Varaljai R; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Castelletti D; Department of Dermatology, Fachklinik Hornheide, Münster, Germany.
  • Kim J; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Dakappagari N; Novartis Pharma AG, Basel, Switzerland.
  • Schultz K; Navigate BioPharma Services, Inc. (a Novartis subsidiary), Carlsbad, California.
  • Robert C; Navigate BioPharma Services, Inc. (a Novartis subsidiary), Carlsbad, California.
  • Long GV; Oncology Precision Medicine, Novartis, Cambridge, Massachusetts.
  • Nathan PD; Gustave Roussy and Paris-Sud-Paris-Saclay University, Villejuif, France.
  • Ribas A; Melanoma Institute Australia and Sydney Medical School, The University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.
  • Flaherty KT; Mount Vernon Cancer Centre, Northwood, United Kingdom.
  • Karaszewska B; Department of Medicine, University of California-Los Angeles, Los Angeles, California.
  • Schachter J; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.
  • Sucker A; Przychodnia Lekarska Komed, Konin, Poland.
  • Schmid KW; The Ella Lemelbaum Institute for Immuno-Oncology and Melanoma, Sheba Medical Center, Tel Hashomer, and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel.
  • Zimmer L; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Livingstone E; Department of Pathology, University Hospital Essen, Essen, Germany.
  • Gasal E; Ruhrlandklinik, West German Lung Center, University Hospital Essen, University of Duisburg-Essen, Germany.
  • Schadendorf D; German Cancer Consortium, Heidelberg, Germany.
  • Roesch A; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Clin Cancer Res ; 27(16): 4500-4510, 2021 08 15.
Article en En | MEDLINE | ID: mdl-34108180
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Oximas / Piridonas / Pirimidinonas / Neoplasias Cutáneas / Linfocitos B / Protocolos de Quimioterapia Combinada Antineoplásica / Imidazoles / Melanoma Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Oximas / Piridonas / Pirimidinonas / Neoplasias Cutáneas / Linfocitos B / Protocolos de Quimioterapia Combinada Antineoplásica / Imidazoles / Melanoma Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Suiza